SC 13G | 2015-02-09 | FRANKLIN RESOURCES INC | KERYX BIOPHARMACEUTICALS INC | 5,344,500 | 5.8% | EDGAR |
SC 13G/A | 2015-02-02 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 5,074,858 | 5.5% | EDGAR |
SC 13G/A | 2014-10-09 | BAUPOST GROUP LLC/MA | KERYX BIOPHARMACEUTICALS INC | 0 | 19.9% | EDGAR |
SC 13G | 2014-05-19 | Flynn James E | KERYX BIOPHARMACEUTICALS INC | 4,455,625 | 4.9% | EDGAR |
SC 13G | 2014-05-09 | BAUPOST GROUP LLC/MA | KERYX BIOPHARMACEUTICALS INC | 9,151,600 | 10.1% | EDGAR |
SC 13G/A | 2014-02-14 | RA CAPITAL MANAGEMENT, LLC | KERYX BIOPHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2014-02-14 | Flynn James E | KERYX BIOPHARMACEUTICALS INC | 1,196,878 | 1.4% | EDGAR |
SC 13G/A | 2014-01-29 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 4,937,277 | 6.0% | EDGAR |
SC 13G/A | 2013-04-10 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 8,559,476 | 10.5% | EDGAR |
SC 13G | 2013-02-15 | RA CAPITAL MANAGEMENT, LLC | KERYX BIOPHARMACEUTICALS INC | 5,285,000 | 6.5% | EDGAR |
SC 13G | 2013-02-15 | Flynn James E | KERYX BIOPHARMACEUTICALS INC | 4,739,082 | 5.9% | EDGAR |
SC 13G/A | 2013-02-11 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 3,957,841 | 5.5% | EDGAR |
SC 13G/A | 2012-02-14 | BALYASNY ASSET MANAGEMENT LLC | KERYX BIOPHARMACEUTICALS INC | 294,258 | 0.4% | EDGAR |
SC 13G | 2012-02-09 | BlackRock Inc. | KERYX BIOPHARMACEUTICALS INC | 3,739,460 | 5.3% | EDGAR |
SC 13G/A | 2011-10-11 | FMR LLC | KERYX BIOPHARMACEUTICALS INC | 875,800 | 1.3% | EDGAR |
SC 13G | 2011-05-06 | BALYASNY ASSET MANAGEMENT LLC | KERYX BIOPHARMACEUTICALS INC | 2,381,904 | 3.5% | EDGAR |
SC 13G | 2011-02-14 | FMR LLC | KERYX BIOPHARMACEUTICALS INC | 4,107,100 | 6.7% | EDGAR |
SC 13G/A | 2010-02-16 | Empery Asset Management, LP | KERYX BIOPHARMACEUTICALS INC | - | 2.6% | EDGAR |
SC 13G | 2009-10-01 | Empery Asset Management, LP | KERYX BIOPHARMACEUTICALS INC | 3,917,574 | 7.0% | EDGAR |
SC 13G/A | 2009-02-18 | GREAT POINT PARTNERS LLC | KERYX BIOPHARMACEUTICALS INC | 15,000 | 0.0% | EDGAR |